Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.
Dated: November 1, 2017 | ||||||
Kerrisdale Partners Master Fund Ltd | ||||||
Signature: | /s/ Sahm Adrangi | |||||
Name: Sahm Adrangi | ||||||
Title: Director | ||||||
Kerrisdale Advisers, LLC | ||||||
Signature: | /s/ Sahm Adrangi | |||||
Name: Sahm Adrangi | ||||||
Title: Managing Member | ||||||
/s/ Sahm Adrangi | ||||||
Sahm Adrangi | ||||||
